Morgan Stanley’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,372
| Closed | -$305K | – | 8126 |
|
|
2024
Q2 | $305K | Sell |
8,372
-12,824
| -61% | -$463K | ﹤0.01% | 5499 |
|
|
2024
Q1 | $806K | Sell |
21,196
-20,110
| -49% | -$747K | ﹤0.01% | 5084 |
|
|
2023
Q4 | $1.5M | Buy |
41,306
+31,308
| +313% | +$935K | ﹤0.01% | 5103 |
|
|
2023
Q3 | $301K | Sell |
9,998
-6,360
| -39% | -$214K | ﹤0.01% | 5395 |
|
|
2023
Q2 | $588K | Sell |
16,358
-1,932
| -11% | -$69.2K | ﹤0.01% | 5127 |
|
|
2023
Q1 | $607K | Sell |
18,290
-2,446
| -12% | -$85.1K | ﹤0.01% | 5141 |
|
|
2022
Q4 | $697K | Sell |
20,736
-4,681
| -18% | -$158K | ﹤0.01% | 5064 |
|
|
2022
Q3 | $874K | Sell |
25,417
-922
| -4% | -$33.5K | ﹤0.01% | 4954 |
|
|
2022
Q2 | $849K | Buy |
26,339
+585
| +2% | +$19.5K | ﹤0.01% | 5116 |
|
|
2022
Q1 | $1.02M | Sell |
25,754
-15,916
| -38% | -$629K | ﹤0.01% | 4982 |
|
|
2021
Q4 | $1.97M | Sell |
41,670
-59,678
| -59% | -$3.08M | ﹤0.01% | 4597 |
|
|
2021
Q3 | $5.54M | Sell |
101,348
-50,161
| -33% | -$2.84M | ﹤0.01% | 3570 |
|
|
2021
Q2 | $9.22M | Buy |
151,509
+35,572
| +31% | +$2.04M | ﹤0.01% | 3085 |
|
|
2021
Q1 | $6.71M | Buy |
115,937
+115,511
| +27,115% | +$7.23M | ﹤0.01% | 3093 |
|
|
2020
Q4 | $25K | Buy |
+426
| New | +$23K | ﹤0.01% | 6370 |
|
Morgan Stanley's BTEC Position: Q3 2024 in Review
Morgan Stanley sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 8,372 shares — an estimated $305K sold.
Morgan Stanley first reported a position in BTEC in Q4 2020 and held it in 15 quarters. The position peaked at $9.22M in Q2 2021. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- Morgan Stanley reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- Morgan Stanley sold 8,372 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $305K.
- Morgan Stanley first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2020 and held it in 15 quarters.
- Morgan Stanley's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $9.22M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.